Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CHANTS: Non-typhoidal Salmonella Human Challenge Model
NCT05870150Active, not recruiting
- Sponsor
- Imperial College Healthcare NHS Trust
- Start
- Aug 2023
- Primary completion
- Feb 2026
- Countries
- 1
01
Overview
Randomised, double-blind trial (2 arms), sponsored by Imperial College Healthcare NHS Trust. Primary endpoint: Dose required for 60-75% of volunteers to develop systemic Salmonellosis. Started Aug 2023; status: active, not recruiting.
Beyond the preview
Go deeper on NCT05870150.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05870150.